Sarcopenia, the degenerative loss of skeletal muscle mass, quality and strength, lacks early diagnostic tools and new therapeutic strategies to prevent the frailty-to-disability transition often responsible for the medical institutionalization of elderly individuals. Herein we report that production of the endogenous peptide apelin, induced by muscle contraction, is reduced in an age-dependent manner in humans and rodents and is positively associated with the beneficial effects of exercise in older persons. Mice deficient in either apelin or its receptor (APLNR) presented dramatic alterations in muscle function with increasing age. Various strategies that restored apelin signaling during aging further demonstrated that this peptide considerably enhanced muscle function by triggering mitochondriogenesis, autophagy and anti-inflammatory pathways in myofibers as well as enhancing the regenerative capacity by targeting muscle stem cells. Taken together, these findings revealed positive regulatory feedback between physical activity, apelin and muscle function and identified apelin both as a tool for diagnosis of early sarcopenia and as the target of an innovative pharmacological strategy to prevent age-associated muscle weakness and restore physical autonomy.

The exerkine apelin reverses age-associated sarcopenia / C. Vinel, L. Lukjanenko, A. Batut, S. Deleruyelle, J. Pradère, S. Le Gonidec, A. Dortignac, N. Geoffre, O. Pereira, S. Karaz, U. Lee, M. Camus, K. Chaoui, E. Mouisel, A. Bigot, V. Mouly, M. Vigneau, A.F. Pagano, A. Chopard, F. Pillard, S. Guyonnet, M. Cesari, O. Burlet-Schiltz, M. Pahor, J.N. Feige, B. Vellas, P. Valet, C. Dray. - In: NATURE MEDICINE. - ISSN 1078-8956. - 24:9(2018 Sep 01), pp. 1360-1371. [10.1038/s41591-018-0131-6]

The exerkine apelin reverses age-associated sarcopenia

M. Cesari;
2018-09-01

Abstract

Sarcopenia, the degenerative loss of skeletal muscle mass, quality and strength, lacks early diagnostic tools and new therapeutic strategies to prevent the frailty-to-disability transition often responsible for the medical institutionalization of elderly individuals. Herein we report that production of the endogenous peptide apelin, induced by muscle contraction, is reduced in an age-dependent manner in humans and rodents and is positively associated with the beneficial effects of exercise in older persons. Mice deficient in either apelin or its receptor (APLNR) presented dramatic alterations in muscle function with increasing age. Various strategies that restored apelin signaling during aging further demonstrated that this peptide considerably enhanced muscle function by triggering mitochondriogenesis, autophagy and anti-inflammatory pathways in myofibers as well as enhancing the regenerative capacity by targeting muscle stem cells. Taken together, these findings revealed positive regulatory feedback between physical activity, apelin and muscle function and identified apelin both as a tool for diagnosis of early sarcopenia and as the target of an innovative pharmacological strategy to prevent age-associated muscle weakness and restore physical autonomy.
Biochemistry, Genetics and Molecular Biology (all)
Settore MED/09 - Medicina Interna
Article (author)
File in questo prodotto:
File Dimensione Formato  
The exerkine apelin reverses age-associated sarcopenia. - Vinel et al. (2018).pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.45 MB
Formato Adobe PDF
2.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/603407
Citazioni
  • ???jsp.display-item.citation.pmc??? 87
  • Scopus 143
  • ???jsp.display-item.citation.isi??? 138
social impact